SCHEMBL16639051

SCHEMBL16639051

C=C1NC2(C(=O)OCC)CC2/C=C\CCCCC[C@@H](CC(=O)N2CCCCC2)C(=O)N2CCC[C@@H]12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16938902 0.92 HDAC4 (0.32) —
SCHEMBL13340505 0.81 FAP (0.33) —
SCHEMBL16639055 0.81 L3MBTL1 (0.36) —
SCHEMBL16938974 0.81 FAP (0.34) —
SCHEMBL16938907 0.79 FAP (0.32) —
SCHEMBL16938890 0.79 FAP (0.32) —
SCHEMBL11975940 0.78 HDAC4 (0.33) —
SCHEMBL8249373 0.77 DPP4 (0.37) —
SCHEMBL16938889 0.75 CTSB (0.40) —
SCHEMBL13340502 0.75 FAP (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374812-B1 4-amino-4-oxobutanoyl Peptides as Inhibitors of Viral Replication ACHILLION PHARMACEUTICALS INC (US) 2015-04-15 — — EP disclosed
Send feedback